L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults
L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults
Sponsor: NIMH National Institute of Mental Health
Enrolling: Male and Female Patients
Study Length: 8 Weeks
Clinic Visits: 10
IRB Number: 7733
U.S. Govt. ID: NCT03761030
Contact: Manya Balachander: 646-774-8677 / manya.balachander@nyspi.columbia.edu
Additional Study Information: In this research study, you will receive a medication called carbidopa/levodopa (Sinemet). This medication is approved by the Food and Drug Administration for the treatment of Parkinson's Disease. We are using carbidopa/levodopa off-label in this study to see whether it is capable of improving depressive symptoms as well as mental and physical slowing that occur as people age.
This study is closed
Investigator
Bret Rutherford, MD
Do You Qualify?
Are you 60 years or older? Yes No
Are you depressed? Yes No
Have you been feeling mentally or physically slowed down? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Manya Balachander
manya.balachander@nyspi.columbia.edu
646-774-8677